Abstract
This Special Issue contains thirteen articles that provide a vivid snapshot of the state-of-the-art of molecular modeling in drug design, illustrating recent advances and critically discussing important challenges [...].
Highlights
The eight Original Research Articles, three Reviews, one Opinion, and one Perspective explore the application of computational methods, ranging from virtual screening and pharmacophore modelling through artificial intelligence and machine learning to molecular dynamics simulation and enhanced sampling to drug design against diverse targets, including protein-protein interfaces and membrane protein receptors
Three of the Original Research Articles describe the application of enhanced molecular dynamics (MD) simulation methods to drug design problems
Cao et al [1] investigated ligand recognition in the neuronal adenosine receptor type 2A. This G-protein coupled receptor (GPCR), a promising drug target for neurogenerative diseases, was embedded in a solvated neuronal-like membrane and its interaction with a high-affinity antagonist was studied by well-tempered metadynamics
Summary
Three of the Original Research Articles describe the application of enhanced molecular dynamics (MD) simulation methods to drug design problems. This Special Issue contains thirteen articles that provide a vivid snapshot of the state-of-the-art of molecular modeling in drug design, illustrating recent advances and critically discussing important challenges.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.